23.07
price down icon0.56%   -0.13
after-market Dopo l'orario di chiusura: 23.00 -0.07 -0.30%
loading
Precedente Chiudi:
$23.20
Aprire:
$23.04
Volume 24 ore:
44,922
Relative Volume:
0.43
Capitalizzazione di mercato:
$333.96M
Reddito:
$1.80M
Utile/perdita netta:
$1.76B
Rapporto P/E:
0.1944
EPS:
118.674
Flusso di cassa netto:
$-149.23M
1 W Prestazione:
-2.33%
1M Prestazione:
+56.30%
6M Prestazione:
+75.44%
1 anno Prestazione:
+71.52%
Intervallo 1D:
Value
$22.59
$23.59
Intervallo di 1 settimana:
Value
$21.00
$24.75
Portata 52W:
Value
$10.80
$24.75

Inhibrx Biosciences Inc Stock (INBX) Company Profile

Name
Nome
Inhibrx Biosciences Inc
Name
Telefono
(858) 795-4220
Name
Indirizzo
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
Name
Dipendente
161
Name
Cinguettio
Name
Prossima data di guadagno
2024-05-24
Name
Ultimi documenti SEC
Name
INBX's Discussions on Twitter

Confronta INBX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
INBX
Inhibrx Biosciences Inc
23.07 330.92M 1.80M 1.76B -149.23M 118.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Inhibrx Biosciences Inc Stock (INBX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-07-23 Iniziato JMP Securities Mkt Perform
2024-01-23 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2022-03-16 Iniziato SMBC Nikko Outperform
2021-09-21 Iniziato JMP Securities Mkt Outperform
2021-04-26 Ripresa Credit Suisse Outperform
2020-09-14 Iniziato Credit Suisse Outperform
2020-09-14 Iniziato Evercore ISI Outperform
Mostra tutto

Inhibrx Biosciences Inc Borsa (INBX) Ultime notizie

pulisher
Jul 24, 2025

Why Inhibrx Biosciences Inc. stock is on top investor watchlistsSignificant capital appreciation - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

GHCL Limited (GHCL) Announces Strategic ShiftRapid portfolio appreciation - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Coastal Financial Corporation stock priceExceptional financial outcomes - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Inhibrx Biosciences Inc. stockExceptional gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is Inhibrx Biosciences Inc. a good long term investmentTriple-digit returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

T.T. Limited (TTL) vs yyyExceptional earning trajectories - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is FCCO a good long term investmentRapid wealth multiplication - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Appian Corporation stockRecord-setting profit potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Top Quality Stocks Trusted Financial InsightsSuperior risk-adjusted returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is CAPL a good long term investmentOutstanding capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Inhibrx Biosciences Inc. stock priceRapid return acceleration - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Drilling Tools International Corporation stockOutstanding risk-reward balance - Autocar Professional

Jul 22, 2025
pulisher
Jul 21, 2025

How Technology Stocks Are Reshaping India’s Market Insider Stock RecommendationsTremendous return rates - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Inhibrx Biosciences Inc. Stock Analysis and ForecastGame-changing returns - jammulinksnews.com

Jul 21, 2025
pulisher
Jul 20, 2025

Top Stocks for Hedge Fund Investments Elite Trader Market TipsBreakthrough profit margins - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

Best Stocks for Aggressive Investors in India High Value Stock PicksBreakthrough profits - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

why ivda stock attracts strong analyst attentionFree Access to Community with 300% Return - Newser

Jul 20, 2025
pulisher
Jul 18, 2025

What drives SERV stock priceHigh-performance investment picks - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

What drives PLAB stock priceExceptional stock performance - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Inhibrx Biosciences: Seeing Soon If The Momentum Is Just Hype - Seeking Alpha

Jul 18, 2025
pulisher
Jul 17, 2025

Why Inhibrx Biosciences Inc. stock attracts strong analyst attentionHigh Return Setup Scanner - beatles.ru

Jul 17, 2025
pulisher
Jul 15, 2025

What makes Inhibrx Biosciences Inc. stock price move sharplyROI Driven Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Inhibrx Biosciences Inc. stock performs during market volatilitySmall Risk Large Return Trades - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

(INBX) Trading Signals - news.stocktradersdaily.com

Jul 10, 2025
pulisher
Jul 08, 2025

Why INBX Is A Stock To Watch In 2025 - RTTNews

Jul 08, 2025
pulisher
Jun 30, 2025

Inhibrx Biosciences, Inc.(NasdaqGS: INBX) dropped from Russell Microcap Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

How To Trade (INBX) - news.stocktradersdaily.com

Jun 30, 2025
pulisher
Jun 30, 2025

Inhibrx Biosciences, Inc.(NasdaqGS: INBX) added to Russell 2000 Defensive Index - MarketScreener

Jun 30, 2025
pulisher
May 28, 2025

Inhibrx Biosciences Concludes 2025 Annual Stockholders Meeting - TipRanks

May 28, 2025
pulisher
May 15, 2025

Inhibrx Reports First Quarter 2025 Financial Results - BioSpace

May 15, 2025
pulisher
May 14, 2025

Inhibrx Slashes Q1 Losses by 45%, Reveals Multiple Clinical Trial Readouts Coming in 2025 - Stock Titan

May 14, 2025
pulisher
May 12, 2025

Oropharyngeal Cancer Treatment Market Size in 7MM is expected - openPR.com

May 12, 2025
pulisher
May 12, 2025

Larynx Cancer Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight - openPR.com

May 12, 2025
pulisher
May 12, 2025

Oropharyngeal Cancer Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight - Barchart.com

May 12, 2025
pulisher
May 07, 2025

When the Price of (INBX) Talks, People Listen - news.stocktradersdaily.com

May 07, 2025
pulisher
Apr 05, 2025

(INBX) On The My Stocks Page - news.stocktradersdaily.com

Apr 05, 2025
pulisher
Apr 02, 2025

Change at the top for Phathom as Basta replaces Curran - BioCentury

Apr 02, 2025
pulisher
Apr 01, 2025

Inhibrx Biosciences reshuffles leadership, appoints new CSO and President By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Inhibrx Biosciences reshuffles leadership, appoints new CSO and President - Investing.com India

Apr 01, 2025

Inhibrx Biosciences Inc Azioni (INBX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):